Risk Factors for Hospitalization, Mechanical Ventilation, or Death Among 10 131 US Veterans With SARS-CoV-2 Infection.
Ioannou GN, Locke E, Green P, Berry K, O'Hare AM, Shah JA, Crothers K, Eastment MC, Dominitz JA, Fan VS. · 2020
Read Risk Factors for Hospitalization, Mechanical Ventilation, or Death Among 10 131 US Veterans With SARS-CoV-2 Infection. by Ioannou GN, Locke E, Green P, Berry K, O'Hare AM, Shah JA, Crothers K, Eastment MC, Dominitz JA, Fan VS. (2020) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc7512055.txt.
Introduction
Ioannou and co-authors identify risk factors for hospital care, ventilation, or death among US veterans with SARS-CoV-2. The cohort study used national Veterans Affairs data. It compared patients by test result.
The study covered 88 747 veterans tested for the virus across the VA system. The title cohort counts 10 131 veterans with positive results in the study. Hospital care, ventilation, and death all ran higher in positive patients. Death risk rose with older age, high local disease burden, and greater comorbidity scores. Fever, breathlessness, and abnormal lab results also marked higher risk. Obesity, Black race, Hispanic ethnicity, lung disease, hypertension, and smoking did not link with death. Most deaths came in men aged 50 or older with heavy comorbidity.
Catalog record
| CREATOR | Ioannou GN, Locke E, Green P, Berry K, O'Hare AM, Shah JA, Crothers K, Eastment MC, Dominitz JA, Fan VS. |
|---|---|
| YEAR | 2020 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 40 KB |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |
Browse the full library · About the Tower of Babel
Full text
The opening of the work, from the library's hosted text:
Risk Factors for Hospitalization, Mechanical Ventilation, or Death Among 10 131 US Veterans With SARS-CoV-2 Infection By George N Ioannou, Emily Locke, Pamela Green, Kristin Berry, Ann M O’Hare, Javeed A Shah, Kristina Crothers, McKenna C Eastment, Jason A Dominitz, Vincent S Fan Published in: JAMA Network Open DOI: 10.1001/jamanetworkopen.2020.22310 ABSTRACT Key Points Question What are the risk factors associated with hospitalization, mechanical ventilation, and death among patients with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection? Findings In this national cohort study of 88 747 veterans tested for SARS-CoV-2, hospitalization, mechanical ventilation, and mortality were significantly higher in patients with positive SARS-CoV-2 test results than among those with negative test results. Significant risk factors for mortality included older age, high regional coronavirus disease 2019 burden, higher Charlson Comorbidity Index score, fever, dyspnea, and abnormal results in many routine laboratory tests; however, obesity, Black race, Hispanic ethnicity, chronic obstructive pulmonary disease, hypertension, and smoking were not associated with mortality. Meaning In this study, most deaths from SARS-CoV-2 occurred in patients with age of 50 years or older, male sex, and greater comorbidity burden. INTRODUCTION Infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has a very broad spectrum of clinical severity, ranging from asymptomatic infection to life-threatening illness.1,2 It remains unclear why some patients infected with SARS-CoV-2 develop the severe complications of coronavirus disease 2019 (COVID-19), which include acute respiratory distress syndrome (ARDS) and death. Multiple risk factors for developing severe COVID-19 disease have been reported, including sociodemographic factors and comorbid conditions.1,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,20,21,22,23,24 However, most prior studies, particularly those published earlier in the course of the pandemic, did not include multivariable adjustment to identify independent risk factors, and few studies examined a range of different disease outcomes, including hospitalization, mechanical ventilation, and death. Most prior studies have been local or regional, rather than national, in scope. Finally, most studies have not compared patients who tested positive for SARS-CoV-2 with those who tested negative to determine the excess risk associated with SARS-CoV-2 infection itself as opposed to other underlying comorbid conditions in patients who happen to have SARS-CoV-2 infection. To address this knowledge gap, we used national data from the Department of Veterans Affairs (VA) health care system to determine the risk of hospitalization, mechanical ventilation, and death associated with infection and to identify characteristics independently associated with these outcomes in patients who tested positive for SARS-CoV-2. METHODS Data Source and Study Population The VA supports the largest integrated national health care system in the United States and provides care for more than 6 million veterans annually. The VA uses a single, national comprehensive electronic health care information network. We derived data from the VA’s Corporate Data Warehouse, a data repository of electronic medical records, developed by the VA Informatics and Computing Infrastructure (VINCI) to facilitate research. To support COVID-19 research, VINCI analysts created and are continually updating the COVID-19 Shared Data Resource,25 which includes analytic variables extracted from the Corporate Data Warehouse for all VA enrollees tested for SARS-CoV-2. Using this resource, we identified all VA enrollees (N = 88 747) who had nasopharyngeal swabs tested for SARS-CoV-2 nucleic acid by polymerase chain reaction in inpatient or outpatient VA facilities (including VA nursing homes) between February 28 and May 14, 2020, for any indication, excluding those who were VA employees. Most tests were performed in VA laboratories using the US Food and Drug Administration–approved RealTime (Abbott Laboratories) or Xpert-Xpress (Cepheid) SARS-CoV-2 assays; some were sent to commercial or state public health laboratories, especially during the early days of the pandemic. Cohort members were followed up through June 22, 2020, for study outcomes allowing for a minimum follow-up of 39 days. This study was approved by the institutional review board of the Veterans Affairs Puget Sound Healthcare System, which granted a waiver of informed consent because this was a retrospective cohort study based on an existing database. This study followed the Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) reporting guideline. Definition of Positive or Negative SARS-CoV-2 Status and Index Date Patients were defined as positive for SARS-CoV-2 if they had at least 1 positive polymerase chain reaction test (n = 10 131 [11.4%]) during the ascertainment period. Patients were defined as negative for SARS-CoV-2 if all polymerase chain reaction tests were negative (n = 78 616 [88.6%]). Final adjudication of SARS-CoV-2 status was performed by the VA National Surveillance Tool, which is intended to be the single, authoritative data source for the determination of positive and negative cases within the Veterans Health Administration. The index date for all analyses was defined as the date of the earliest positive test (for patients with SARS-CoV-2) or the date of the earliest negative test (for patients with no SARS-CoV-2), unless the patient had been admitted to a VA hospital during the preceding 15 days, in which case the date of admission served as the index date. Adverse Outcomes We determined the following 3 outcomes: (1) hospitalization at the index date or within 15 days of the index date, (2) mechanical ventilation at the index date or within 60 days, and (3) all-cause mortality at any time after the index date. Deaths that occurred both in and out of the VA are comprehensively captured in the Corporate Data Warehouse through a variety of sources, including VA inpatient files, VA Beneficiary Identification and Records Locator System, Social Security Administration death files, and the Department of Defense.26 Episodes of mechanical ventilation and hospitalization that occurred outside the VA were captured only if the VA paid for these hospitalizations at non-VA facilities under the VA Community Care program. Baseline Characteristics Evaluated for Associations With Adverse Outcomes We included characteristics that were evaluated in prior studies or that we hypothesized might be associated with adverse outcomes. Baseline sociodemographic characteristics included age, sex, race, ethnicity, body mass index (calculated as weight in kilograms divided by height in meters squared), urban vs rural residence (based on zip codes), and regional per capita COVID-19–related mortality, operationalized as the number of COVID-19–related deaths per million residents in each participant’s state of residence as of June 11, 2020 (Table 1).27 [Table: Associations Between Sociodemographic Characteristics and Hospitalization, Mechanical Ventilation, or Mortality Among 10 131 Patients Who Tested Positive for SARS-CoV-2 Between February 28 and May 14, 2020] Comorbid conditions were extracted by VINCI analysts based on International Classification of Diseases and Related Health Problems, Tenth Revision (ICD-10) recorded in VA electronic health records during the 2-year period on or before the index date.25 We used the Charlson Comorbidity Index (CCI) to estimate the overall burden of comorbidity (Table 2). [Table: Associations Between Comorbid Conditions and Hospitalization, Mechanical Ventilation, or Mortality Among 10 131 VA Patients Who Tested Positive for SARS-CoV-2 Between February 28 and May 14, 2020] We also included documented symptoms thought to be related to SARS-CoV-2, identified by VINCI analysts based on a combination of natural language processing of text notes in patients’ electronic medical records and searching for relevant ICD-10 codes,25 occurring on or within 30 days prior to the index date (Table 3). We do not report associations with loss of smell or taste, given that these symptoms were not widely recognized during the ascertainment period and thus rarely